# Liposomal Ivermectin This page covers the experimental liposomal ivermectin material in this section. It is one of the highest-risk topics here. That is why the emphasis on safety is stronger than usual. {% hint style="danger" %} No formal approval exists for routine human use of liposomal ivermectin. Oral liposomal ivermectin remains experimental. Extreme caution is warranted, especially with high dosing, CNS risk, or fenbendazole co-use. {% endhint %} ### What the preclinical studies suggest The early literature points in one direction: * higher intracellular uptake * improved delivery performance in preclinical systems * lower apparent cytotoxicity than free ivermectin in some models ### Key studies cited #### 1. Enhanced intracellular uptake and reduced toxicity * Enhancing Intracellular Uptake of Ivermectin through Liposomal Encapsulation: An In Vitro Study * *Reported uptake range: **13–60%** for liposomal ivermectin versus about **2%** for free ivermectin in the cited system* * #### 2. Antiviral activity against the dengue virus * Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin * #### 3. In vitro antiviral potency * Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system ### Practical interpretation These papers support a cautious conclusion. Liposomal ivermectin may: * increase delivery into cells * improve pharmacokinetic behaviour * improve tissue targeting * reduce free-drug cytotoxicity in some systems That still does **not** make DIY use simple or automatically safe. ### Other pages in this section * [How to Use Empty Liposomes](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds.md) * [Why Empty Liposomes Matter](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/why-empty-liposomes-matter.md) * [Safety, Timing, and Stacking Cautions](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/safety-timing-and-stacking-cautions.md) * [How to Use Liposence® Empty Liposomes](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/how-to-use-liposence-r-empty-liposomes.md) * [DIY Liposomal Melatonin](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/diy-liposomal-melatonin.md) * [Nebulising Liposomal Formulations](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/nebulising-liposomal-formulations.md) ### Practical considerations
Solubility and compatibility Ivermectin is **highly hydrophobic**. It is practically insoluble in water. It is much more compatible with organic solvents such as ethanol or methanol. That is one reason liposomal encapsulation is being explored.
Why liposomal delivery may be attractive Liposomal ivermectin may offer: * substantially higher cellular uptake * improved bioavailability * better tissue targeting * protection from enzymatic degradation * reduced cytotoxicity in some preclinical settings
Size and encapsulation questions **80–200 nm** liposomes are often described as a common and effective range. It also notes that some positively charged liposomes can be smaller. Encapsulation efficiency is often reported above **80%**. Optimised research methods sometimes report **95–100%**.
Storage and stability Cool storage is preferred. Refrigeration is preferred. It also notes that some members are using amber syringes with caps for pre-measured daily doses. Those syringes may help with: * light protection * faster dosing * labelling * safer fridge storage away from children
Regulatory note Ivermectin is prescription-only in Australia and many other countries for oral use. Liposomal ivermectin is not formally approved by the TGA for human use. This remains an experimental area and is subject to local regulation.
### Worked recipe example One worked example uses: * **1 gram ivermectin** * **7 mL of 96-proof alcohol** * **10 mL of MCS Liposence** That gives a total volume of: * **17 mL** ### Concentration math * total ivermectin: **1,000 mg** * total volume: **17 mL** * concentration: `1,000 mg ÷ 17 mL ≈ 58.82 mg/mL` ### Dose per 0.5 mL * `58.82 mg/mL × 0.5 mL ≈ 29.41 mg` That rounds to: * **about 30 mg ivermectin per 0.5 mL** ### Starting-dose caution Extra caution makes sense the first time. One conservative approach is to halve the usual dose when switching to a liposomal formulation. The example given is: * if someone usually takes **30 mg oral powder** * a safer first liposomal starting point may be **0.25 mL** rather than **0.5 mL** That is still experimental guidance only. It is not a validated dosing protocol. ### Handling tips * swirl or shake gently before each dose * use an accurate syringe for small volumes * store smaller batches in the fridge * label bottles or syringes clearly ### Important safety considerations Timing matters. What is *already in your blood* matters. Fenbendazole is used as the example. The concern is that fenbendazole is: * slower to absorb than ivermectin * able to peak many hours later * potentially still present when a later liposomal dose is introduced That matters because liposomes may make cell entry easier not only for the intended payload, but sometimes also for fat-soluble compounds still circulating nearby. ### Fenbendazole timing concern The practical concern is: * fenbendazole may peak anywhere from **3–30 hours** later * average estimates are roughly **6–12 hours** * half-life ranges discussed in the literature are about **10–30 hours** across studies and species That is one reason wider spacing is sensible. ### Member report kept clearly separate {% hint style="info" %} #### Member report A community report describes taking **200 mg liposomal mebendazole made with MCS Liposense** about **2 hours after 30 mg powdered ivermectin**. The reported effects were stronger and more difficult to tolerate than with previous non-liposomal use within a similar time window. This is a personal report. It is not trial evidence. It still matters because it shows that liposomal delivery may radically change tolerability. {% endhint %} ### Bottom line Liposomal ivermectin is biologically interesting and of high practical risk. The two most important takeaways are: * **go gradually** * **go safely** That means: * lower starting doses * wider spacing * careful monitoring * much more respect for CNS exposure questions → [Back to How to Use Empty Liposomes](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds.md) → [Previous: DIY Liposomal Melatonin](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/diy-liposomal-melatonin.md)\ → [Next: Nebulising Liposomal Formulations](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/nebulising-liposomal-formulations.md) {% hint style="warning" %} This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use. {% endhint %} {% hint style="info" %} © 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text. {% endhint %} --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/liposomal-ivermectin.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.